Published in Gastroenterology on February 01, 1993
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol (2012) 4.47
Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology (2013) 4.43
Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38
Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34
Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg (1995) 2.17
Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05
Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut (1998) 1.98
Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75
Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut (2005) 1.74
Cost effectiveness of detecting Barrett's cancer. Gut (1996) 1.63
Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut (2001) 1.62
Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg (1997) 1.58
Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study. Gut (1999) 1.48
Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut (2000) 1.46
MET expression and amplification in patients with localized gastric cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.42
Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. Gut (2005) 1.41
Comparative acceptability of transnasal esophagoscopy and esophageal capsule esophagoscopy: a randomized, controlled trial in veterans. Gastrointest Endosc (2014) 1.41
Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut (2002) 1.38
Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg (2007) 1.35
NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg (2004) 1.31
An audit of the treatment of cancer of the oesophagus. Gut (1994) 1.29
DNA methylation: an alternative pathway to cancer. Ann Surg (2001) 1.24
Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg (2003) 1.23
Psychosocial working conditions and the risk of esophageal and gastric cardia cancers. Eur J Epidemiol (2004) 1.18
Barrett's esophagus in Japanese patients: its prevalence, form, and elongation. J Gastroenterol (2008) 1.17
Proton pump inhibitors for Barrett's oesophagus. Gut (2000) 1.14
Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut (1998) 1.14
Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes (2013) 1.13
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg (2006) 1.12
Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc (2008) 1.10
Barrett's esophagus: histopathologic definitions and diagnostic criteria. World J Surg (2004) 1.10
Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut (1996) 1.08
Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg (2003) 1.08
The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer (2002) 1.07
Trend in gastric cancer: 35 years of surgical experience in Japan. World J Gastroenterol (2011) 1.05
Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol (2008) 1.04
Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol (2008) 1.03
Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. Ann Surg (2000) 1.02
Detection of adenocarcinoma in Barrett's oesophagus by means of laser induced fluorescence. Gut (1996) 1.01
Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas. Neoplasia (2008) 1.00
Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia. World J Gastroenterol (2011) 1.00
Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg (1998) 1.00
Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions: a histopathological comparison during 24-year period. World J Surg (2008) 0.98
Helicobacter pylori and gastroesophageal reflux disease. World J Surg Oncol (2008) 0.97
Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. World J Gastroenterol (2003) 0.97
Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer. Gastric Cancer (2012) 0.96
Cyclooxygenase-2 expression in Barrett's esophagus. Dig Dis Sci (2001) 0.96
Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. Am J Pathol (2001) 0.95
Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol (2003) 0.95
Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus. Dig Dis Sci (2001) 0.95
Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma. J Surg Oncol (2012) 0.93
Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg (2004) 0.93
Barrett's esophagus. The significance of p53 in clinical practice. Ann Surg (1997) 0.93
Comparative studies on epithelial lesions at gastric cardia and pyloric antrum in subjects from a high incidence area for esophageal cancer in Henan, China. World J Gastroenterol (1998) 0.92
Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma. World J Gastroenterol (2006) 0.92
Magnification endoscopy and chromoendoscopy in evaluation of specialized intestinal metaplasia in Barrett's Esophagus. Dig Dis Sci (2011) 0.91
Differences in gastric cancer survival between the U.S. and China. J Surg Oncol (2015) 0.91
Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg (2004) 0.91
H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci (2010) 0.89
Discovery of new molecular subtypes in oesophageal adenocarcinoma. PLoS One (2011) 0.89
Site distribution of oesophagogastric cancer. J Clin Pathol (2002) 0.89
A case of esophageal adenocarcinoma metastasized to the scalp. Ann Dermatol (2009) 0.89
Gallstones increase the prevalence of Barrett's esophagus. J Gastroenterol (2009) 0.88
The aging oesophagus. Gut (1997) 0.87
Time gated fluorescence spectroscopy in Barrett's oesophagus. Gut (2003) 0.87
On the origin of cardiac mucosa: a histological and immunohistochemical study of cytokeratin expression patterns in the developing esophagogastric junction region and stomach. World J Gastroenterol (2005) 0.87
Sex difference in survival of patients treated by surgical resection for esophageal cancer. World J Surg (2007) 0.87
c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus. J Clin Pathol (1995) 0.87
Laparoscopically assisted transhiatal resection for malignancies of the distal esophagus. Surg Endosc (2004) 0.87
Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences. World J Surg (2006) 0.86
Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Protagonist. Gut (2002) 0.86
The gastric cardia in gastro-oesophageal disease. J Clin Pathol (2000) 0.86
Effect of body mass index on adenocarcinoma of gastric cardia. World J Gastroenterol (2003) 0.86
Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas. Neoplasia (2005) 0.85
Role of surveillance in intestinal metaplasia of the esophagus and gastroesophageal junction. World J Surg (2003) 0.85
Immunohistochemical study of nuclear factor-kappaB activity and interleukin-8 abundance in oesophageal adenocarcinoma; a useful strategy for monitoring these biomarkers. J Clin Pathol (2007) 0.85
Can Western endoscopists identify the end of the lower esophageal palisade vessels as a landmark of esophagogastric junction? J Gastroenterol (2009) 0.84
Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach. Br J Cancer (2007) 0.84
Correlation between endoscopic macroscopic type and invasion depth for early esophagogastric junction adenocarcinomas. Gastric Cancer (2011) 0.84
Radiofrequency ablation in the management of Barrett's esophagus - preliminary own experience. Wideochir Inne Tech Maloinwazyjne (2013) 0.83
Clinical epidemiology of gastric cancer in Hehuang valley of China: a 10-year epidemiological study of gastric cancer. World J Gastroenterol (2014) 0.83
Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus. Dig Dis Sci (1997) 0.83
Trends in esophageal cancer and body mass index by race and gender in the state of Michigan. BMC Gastroenterol (2009) 0.82
Barrett's esophagus. Dig Dis Sci (2000) 0.82
A single center's 30 years' experience of esophageal adenocarcinoma. Korean J Intern Med (2001) 0.81
Inflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infection. J Clin Pathol (2005) 0.81
Etiological difference between ultrashort- and short-segment Barrett's esophagus. J Gastroenterol (2010) 0.80
Gastroesophageal reflux and Helicobacter pylori: a review. World J Gastroenterol (2000) 0.80
Primary esophageal adenocarcinoma arising from heterotopic gastric mucosa: report of a case. Surg Today (2012) 0.80
Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia. J Clin Pathol (2005) 0.80
Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma. Dig Dis Sci (2006) 0.80
Totally laparoscopic trans-hiatal gastroesophagectomy for benign diseases of the esophago-gastric junction. World J Gastroenterol (2007) 0.80
Crossroads in the combined-modality management of gastroesophageal junction carcinomas. Gastrointest Cancer Res (2008) 0.80
Changing pattern of esophageal cancer incidence in New Mexico: a 30-year evaluation. Dig Dis Sci (2009) 0.79
Occupational mortality from squamous cell carcinoma of the esophagus in the United States during 1991-1996. Dig Dis Sci (2002) 0.79
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Circulation (2010) 7.03
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67
Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84
Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60
Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59
Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52
The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med (1985) 4.30
Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16
A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85
Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60
Inflammatory pseudotumors of the lung. Ann Thorac Surg (1999) 3.51
A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43
Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med (2003) 3.39
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
Lobar torsion after pulmonary resection: presentation and outcome. J Thorac Cardiovasc Surg (2001) 3.16
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12
Epiphrenic diverticulum: results of surgical treatment. Ann Thorac Surg (1993) 3.04
Associations of TV viewing and physical activity with the metabolic syndrome in Australian adults. Diabetologia (2005) 3.02
Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology (1993) 2.99
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86
Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Splenic artery aneurysms. Surgery (1982) 2.61
Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology (1990) 2.56
Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54
Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52
Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc (1997) 2.36
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Colorectal lung metastases: results of surgical excision. Ann Thorac Surg (1992) 2.25
Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23
Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol (1997) 2.23
Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology (1995) 2.23
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22
Postoperative chylothorax. J Thorac Cardiovasc Surg (1996) 2.19
Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17
Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.13
Primary chest wall tumors: factors affecting survival. Ann Thorac Surg (1986) 2.12
Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12
Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11
Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09
Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol (1994) 2.08
Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther (2014) 2.08
Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg (2000) 2.05
Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology (1993) 2.03
Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol (1996) 2.01
Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol (1995) 1.99
Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol (1995) 1.94
Predictors of outcome after percutaneous endoscopic gastrostomy: a community-based study. Mayo Clin Proc (1992) 1.94
Lipoprotein analysis in the evaluation of chest pain in the emergency department. Mayo Clin Proc (1991) 1.92
Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA (1997) 1.89
Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms. Am J Gastroenterol (1998) 1.88
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.85
Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol (1994) 1.85
MR imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology (1990) 1.84
Primary non-Hodgkin's lymphoma of the lung. Ann Thorac Surg (2000) 1.83
Early and long-term results of prosthetic chest wall reconstruction. J Thorac Cardiovasc Surg (1999) 1.83
Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut (1988) 1.82
Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci (1995) 1.81
Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol (1985) 1.81
Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc (1999) 1.81
Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc (1987) 1.78
Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg (1990) 1.78
Quality of life after proctocolectomy. A comparison of Brooke ileostomy, Kock pouch, and ileal pouch-anal anastomosis. Gastroenterology (1991) 1.77
Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci (1991) 1.76
Functional constipation and outlet delay: a population-based study. Gastroenterology (1993) 1.74
Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol (1989) 1.73
Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil (2009) 1.73
Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol (2000) 1.71
Increasing incidence of pancreatic cancer among women in Olmsted County, Minnesota, 1940 through 1988. Mayo Clin Proc (1992) 1.69
Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology (1990) 1.69
Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg (1997) 1.68
Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther (2011) 1.68
Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut (1990) 1.68
Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence. Gut (2005) 1.67
Chronic ulcerative colitis: incidence and prevalence in a community. Gut (1987) 1.66
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology (2001) 1.64
Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-beta1, with divergent effects of epidermal growth factor and tumor necrosis factor-alpha on collagen type I and collagen type IV. J Lab Clin Med (1997) 1.64
Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc (2000) 1.64
Linear gastric erosion. A lesion associated with large diaphragmatic hernia and chronic blood loss anemia. Gastroenterology (1986) 1.63
Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med (2000) 1.61
Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology (1999) 1.61
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil (2005) 1.60
[13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology (1997) 1.59
Adrenergic modulation of human colonic motor and sensory function. Am J Physiol (1997) 1.59
Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol (1991) 1.59
A new questionnaire for constipation and faecal incontinence. Aliment Pharmacol Ther (2004) 1.58